Deals and Financings
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Sweden's Recipharm has agreed to buy UK-based Consort Medical for £505m ($652m) to become a leading inhalation-device company.
Latest From Deals
In an example of how so called "digital therapies" can augment traditional drug treatments, Swedish pharma company Orexo has secured exclusive US rights to an AI-based behavioral therapy for the treatment of alcohol use disorder (AUD).
The health-care sector remains ripe for investments, according to an expert panel of private equity investors. See what Steve Dyson, partner at UK private equity firm Apax Partners, said about it during a panel discussion at the recent Jefferies Healthcare Conference in London.
An expert panel of investors at Jefferies Healthcare Conference in London discussed the landscape for private equity investment in health-care businesses.
Terumo is acquiring the vascular therapy company to boost its AAA graft business.
Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, research and development partnerships and commercial collaborations. This edition covers industry pacts that were signed in September and October 2019.
Stryker is acquiring rival Wright Medical in a $4bn deal catapulting the company to a top position in the trauma and extremities market. See what Stryker CEO Kevin Lobo said about it here.
Thermo Fisher Scientific has signed a collaboration with Cambridge, UK-based Owlstone Medical to identify novel biomarkers.
Google has entered into a definite agreement to buy Fitbit in a deal worth $2.1bn. See what Google’s Rick Osterloh said about it here.
Stryker is acquiring rival Wright Medical in a $4bn deal catapulting the company to a top position in the trauma and extremities market. The agreement, announced on 4 November, is Stryker’s biggest acquisition this year.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.